The immunohistochemica! localization of the calciumbinding protein, S1OO 3, in human nervous system tumors has been examined by using a monodonal antibody with specificity for the S1OO 3 polypeptide. S1OO 3-specific immunoreactivity is detected in astrocytoma, glioblastoma, Schwannoma, ependymoma, and craniopharyngioma, whereas no reactivity is seen in oligodendroglioma, menin-
Although 5100 was orginally considered to be a homogenous protein specific to the nervous system, subsequent characterization has demonstrated that this fraction is a mixture of polypeptides that are not restricted to neural tissue (28) . 5100 immunoreactivity has been detected in several non-neural tissues, including adipose tissue (4,11), 1-lymphocytes (10), and skin (1, 21, 25) . Two major components of bovine brain 5100 preparations, SlOOa and S100 , have been purified and their amino acid sequences determined (6, 7) . SlOOa (7) and 510013 (6) 
Craniopharyngioma
The solid adamantinomatous areas of the tumor clearly demonstrated rich brown cytoplasmic staining for S100 , whereas the epithelial-appearing lining cells and the cystic regions of these neoplasms demonstrated no S100 3 positivity ( Figure  1E ).
Schwannoma
In Schwannomas (Figure iF), S100 staining was lighter or less dense than in the above-described neoplasms. However, a distinct 978 VAN ELDIK, JENSEN, and brain sections have been reported (2, 9, 22, 23, 26) and are therefore available for comparison to the monoclonal antibodies.
EHRENFRIED, WHETSELL
We report here utilization of these monoclonal antibodies to analyze S100 localization in several different tumors of the human nervous system . The results validate the use of these monoclonal antibodies as specific immunochemical reagents for research and diagnostic applications.
Materials and Methods
Bovine brain S100 3 was purified to homogeneity as previously described (14). Highly specific mouse monoclonal antibodies against Si00 3 were produced and characterized as described
Briefly, spleen cells from Balb/C mice that had been immunized with purified bovine S100 3 were fused with mouse myeloma cells (P3X63-Ag8.653).
Antibody-producing hybridomas were cloned by limiting dilution or in soft agar until stable clones were achieved.
The monoclonal antibodies were shown (27) to be specific for the S100 3 polypeptide by enzyme-linked immunosorbent assay, radioimmunoassay, and immunoblot analysis, with little or no reactivity with the SlOOa polypeptide.
To further characterize the distribution of the S100 3 protein in human brain tumors and to begin to assess the usefulness of specific monoclonal antibody as a research tool, we selected a number of neuropathological into the cell process ( Figure  1A ). Zones of necrosis did not show any staining, and the prominent vascular components, including proliferated endothelium, showed no staining.
Astrocytoma
In agreement with previous results (27) showed a rich cytoplasmic stain with the S100 3 antibody ( Figure  1C ). There was no staining in the vascular components of ependymoma specimens.
Mixed Glioma
In neoplasms that had been histologically identified as mixed gliomas containing both astrocytes and oligodendrocytes, only astrocytic cells were observed to stain positively for 510013. Specifically, neoplastic oligodendroglial cells were devoid ofstaining, and the cytoplasm of these cells consistently appeared as clear halos around hematoxylin-counterstained nuclei ( Figure  1D ). stain (arrows) for S100 3 than the other types of tumor cells shown in panels A-E. "streaming" cells comprising the more compact zones of these neoplasms;
in the less compact regions, S100 3 reactivity was not discernible. blastoma specimens. They showed a dark brown stain typical of astrocytic staining with S100 , but these cells were not neoplastic and were considered to be entrapped in the neoplasm. The
Medulloblastoma and Neuroblastoma
cytoplasm of the neoplastic medulloblastoma cells was devoid of Staining and evaluation ofspecimens ofmedulloblastoma and pe-S100 3 staining, a feature which seemed to be more outstanding 1 O: :
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Meningioma
Histologically typical examples of meningiomas demonstrated no cytoplasmic staining for Si00 3 ( Figure  2C ). No other cellular components in these neoplasms took up the S100 stain.
Oligodendroglioma
In specimens that were carefully selected as examples of pure oligodendroglioma, that is, specimens in which there appeared to be no neoplastic astrocytic component, the oligodendroglioma cells showed no staining with the S100 3 antibody ( Figure  2D ). As with the medulloblastoma specimens, there were occasional isolated astrocytes that stained prominently for S100 3.
Discussion
In by the antibody may be "masked" in a particular tissue, or may be altered by fixation and processing conditions. There have been only a few reports (3, 12, 13, 17, 20, 29) on the production of monoclonal antibodies against 5100, and fewer still (3, 12, 17, 29) on their use in immunohistochemical procedures.
In general, the staining patterns obtamed were similar to those seen with conventional polyclonal antibodies.
For example, 5100 immunoreactivity was found in astrocytes in brain sections (3, 12, 29) and optic nerves (17) 
